Earningsreport

Q2/2024 6/30/2024 EPS -0.530 ZacksConsensus -0.500 ActVsEst (0.030) - Miss

Cocrystal Pharma, Inc.  (COCP) 
NASDAQ:AMEX Investor Relations: cocrystalpharma.com